{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2989131", "DateCompleted": {"Year": "1985", "Month": "08", "Day": "12"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "28"}, "Article": {"Language": ["jpn"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0015-5691", "JournalIssue": {"Volume": "85", "Issue": "3", "PubDate": {"Year": "1985", "Month": "Mar"}}, "Title": "Nihon yakurigaku zasshi. Folia pharmacologica Japonica", "ISOAbbreviation": "Nihon Yakurigaku Zasshi"}, "ArticleTitle": "[Pharmacological studies on schizandra fruits. III. Effects of wuweizisu C, a lignan component of schizandra fruits, on experimental liver injuries in rats].", "Pagination": {"StartPage": "193", "EndPage": "208", "MedlinePgn": "193-208"}, "Abstract": {"AbstractText": ["The effects of wuweizisu C, a lignan component of schizandra fruits, on liver injuries induced by carbon tetrachloride (CCl4), d-galactosamine and dl-ethionine were investigated by means of serum-biochemical and histopathological examinations in rats. Pretreatment or combined administration of wuweizisu C dose-dependently reduced the elevation of serum transaminase activity and histological changes such as fatty degeneration, cell necrosis, inflammatory cell infiltration, etc., which were caused by the single administration of 1 ml/kg, p.o., or the repeated administration of 0.2 ml/kg, s.c., daily for 4 days of CCl4, respectively. The effects of wuweizisu C on the liver injuries induced by a low dose (200 mg/kg, i.p.) and a high dose (400 mg/kg, i.p.) of d-galactosamine were compared with those of uridine. Wuweizisu C significantly lowered the rise of serum transaminase activity after the administration of a low dose of d-galactosamine in the serum-biochemical analysis. A tendency was also shown to inhibit cell necrosis and inflammatory cell infiltration caused by both doses of d-galactosamine in the histopathological examination. On the other hand, uridine markedly repaired the serum-biochemical and histopathological changes after the administrations of both doses of d-galactosamine. Also wuweizisu C cured the liver injury by the repeated administration of 150 mg/kg, i.p., daily for 4 days of d-galactosamine. After the repeated administration of 250 mg/kg, s.c., daily for 4 days of ethionine, liver cell atrophy, diffuse fatty degeneration and decrease of serum triglyceride were observed, but not cell necrosis. Wuweizisu C dose-dependently inhibited fatty degeneration and decrease of serum triglyceride. These findings suggest that wuweizisu C can be protective and/or therapeutic on hepatocellular phenomena such as cell necrosis, fatty degeneration, inflammatory cell infiltration, etc., in human hepatitis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Takeda", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Funo", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Iizuka", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kase", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Arai", "ForeName": "I", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ohkura", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sudo", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kiuchi", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Yoshida", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Maeda", "ForeName": "S", "Initials": "S"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Nihon Yakurigaku Zasshi", "NlmUniqueID": "0420550", "ISSNLinking": "0015-5691"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cyclooctanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Polycyclic Compounds"}, {"RegistryNumber": "7535-00-4", "NameOfSubstance": "Galactosamine"}, {"RegistryNumber": "C8754W6B3G", "NameOfSubstance": "schizandrin C"}, {"RegistryNumber": "WX1BN24WZT", "NameOfSubstance": "Ethionine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Carbon Tetrachloride Poisoning"}, {"QualifierName": [], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "Cyclooctanes"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Ethionine"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Fatty Liver"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Galactosamine"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Hepatitis"}, {"QualifierName": [], "DescriptorName": "Lignans"}, {"QualifierName": ["drug therapy", "prevention & control"], "DescriptorName": "Liver Diseases"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Polycyclic Compounds"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Inbred Strains"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1985", "Month": "3", "Day": "1"}, {"Year": "1985", "Month": "3", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1985", "Month": "3", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2989131", "10.1254/fpj.85.193"]}}]}